Friday, May 21, 2021 5:19:31 PM
Recent ANVS News
- Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • InvestorsHub NewsWire • 10/03/2024 12:45:00 PM
- Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • InvestorsHub NewsWire • 10/02/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:38:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:15:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:09:07 PM
- IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 12:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:05:43 PM
- Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News • IH Market News • 07/08/2024 10:37:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 10:05:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:32:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:05:24 PM
- Annovis Announces New Publication in a Peer-Reviewed Journal • GlobeNewswire Inc. • 05/21/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:05:46 PM
- Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:11:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:03:33 PM
- Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 09:12:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:11:19 PM
- Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
- Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease • GlobeNewswire Inc. • 04/29/2024 02:10:00 PM
- Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM